Your are Here :Home> International Exchanges>International Exchanges
RemeGen signs global licensing agreement on anti-cancer drug
2021-08-11Yantai-based biotech innovator RemeGen signed an exclusive worldwide licensing agreement with Seagen Inc on Aug 8.
Yantai's foreign capital in actual use hits record high in H1
2021-07-23The actual use of foreign capital in Yantai reached $1.26 billion, up 51.4 percent in the first half of this year.
RCEP treaty is a chance for better deals, says Henkel vice-president
2021-07-19The signing of the Regional Comprehensive Economic Partnership agreement is a wonderful thing.
Multinational firms see potential in Yantai
2021-07-15Yantai has become a preferred place for multinational firms.
Yantai to deepen cooperation with multinationals
2021-07-14Yantai will host a promotional conference during the second Qingdao Multinationals Summit.
-
Yantai deepens ties with Fortune Global 500 companies
2021-06-30Yantai hosted an online dialogue with the top executives of the world's top 500 enterprises on June 28.